Spinomenal Releases ‘Break the Piggy’ Bank Title
Reading Time: 2 minutes Leading iGaming content provider Spinomenal has enhanced its impressive slot portfolio with the release of Break the Piggy Bank. The game is part of the Classics Series. A vault stacked high with gold coins sets the scene for this fun
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S
Reading Time: 9 minutes The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 10 December 2024 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager,
DanCann Pharma A/S Recommends Experienced Politician and Senior Government Official to Join the Board of Directors
Reading Time: 4 minutes COPENHAGEN, Denmark, 25 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, is pleased to announce its nomination of Jes Lunde to join its Board of Directors at the upcoming Extraordinary General
No. 105, 2024 – Debtor composition in Nordea Kredit (CK 92)
Reading Time: < 1 minute Monthly information on debtor composition in Nordea Kredit published in order to comply with the Transparency Directive’s disclosure requirements. Nordea Kredit hereby publishes monthly data on debtor composition of all callable bond series. The information is subject to disclosure requirements
Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program
Reading Time: < 1 minute ANNOUNCEMENT NO. 254 – 25 NOVEMBER 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements
Clinical evaluation at Karolinska University Hospital is progressing
Reading Time: 2 minutes The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of EndoDrill®, the world’s first market-cleared, electric-driven biopsy instrument for endoscopy, announces that the Company’s clinical evaluation is proceeding at Karolinska University Hospital in Stockholm. During the Company’s visit to
Genetic Analysis AS: Mandatory notification of trade – Primary Insiders
Reading Time: 2 minutes OSLO, NORWAY – 25 November 2024: Genetic Analysis AS (“GA” or “the Company”) announces that members of the management has bought GEAN-shares. Ronny Hermansen, CEO of Genetic Analysis AS, has through the fully owned company InVitroDia AS on Friday 22.11.2024 bought
Inside information: Profit warning – Terveystalo raises its profitability guidance for 2024
Reading Time: 2 minutes Terveystalo Plc, inside information 25 November 2024 at 08:00 EEST Terveystalo raises its profitability guidance for 2024. The guidance for revenue remains unchanged. “In quarter performance so far has been stronger than our forecasts, thanks to a strong demand and further
Aker Solutions ASA: Ex-dividend NOK 21.00 today
Reading Time: < 1 minute November 25, 2024 – The shares in Aker Solutions ASA will be traded ex-dividend NOK 21.00 per share as from today, November 25, 2024. This information is published in accordance with the requirements of the Continuing Obligations. ENDS
Anora expands its footprint in the Baltics by establishing Anora Lithuania
Reading Time: 2 minutes The establishment of Anora Lithuania is a key step in the execution of Anora’s strategy, aimed at scaling Anora’s position in the Baltics to cement its regional leadership. As the largest market of the Baltic countries, Lithuania offers new growth potential for